- call +1-201-465-4211
- email sales@mrinsights.biz
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
Scope of the Report:
This report studies the Endoscope + Radiofrequency Ablation (RFA) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Endoscope + Radiofrequency Ablation (RFA) market by product type and applications/end industries.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
The global Endoscope + Radiofrequency Ablation (RFA) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Endoscope + Radiofrequency Ablation (RFA).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith & Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Focal Ablation
Others
Market Segment by Applications, can be divided into
Cardiology Application
Pain Management
Oncology Application
Other Application
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Endoscope + Radiofrequency Ablation (RFA) Market Overview
1.1 Product Overview and Scope of Endoscope + Radiofrequency Ablation (RFA)
1.2 Classification of Endoscope + Radiofrequency Ablation (RFA) by Types
1.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue Comparison by Types (2017-2023)
1.2.2 Global Endoscope + Radiofrequency Ablation (RFA) Revenue Market Share by Types in 2017
1.2.3 Focal Ablation
1.2.4 Others
1.3 Global Endoscope + Radiofrequency Ablation (RFA) Market by Application
1.3.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cardiology Application
1.3.3 Pain Management
1.3.4 Oncology Application
1.3.5 Other Application
1.4 Global Endoscope + Radiofrequency Ablation (RFA) Market by Regions
1.4.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Endoscope + Radiofrequency Ablation (RFA) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Endoscope + Radiofrequency Ablation (RFA) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endoscope + Radiofrequency Ablation (RFA) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Endoscope + Radiofrequency Ablation (RFA) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endoscope + Radiofrequency Ablation (RFA) Status and Prospect (2013-2023)
1.5 Global Market Size of Endoscope + Radiofrequency Ablation (RFA) (2013-2023)
2 Manufacturers Profiles
2.1 Boston Scientific Corporation Conmed Corporation
2.1.1 Business Overview
2.1.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic Plc (Covidien Plc)
2.2.1 Business Overview
2.2.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Smith & Nephew Plc
2.3.1 Business Overview
2.3.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Smith & Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Stryker Corporation
2.4.1 Business Overview
2.4.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Halyard Health
2.5.1 Business Overview
2.5.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories (St. Jude Medical, Inc.)
2.6.1 Business Overview
2.6.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.7 AngioDynamics
2.7.1 Business Overview
2.7.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hologic
2.8.1 Business Overview
2.8.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hologic Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
2.9 AtriCure
2.9.1 Business Overview
2.9.2 Endoscope + Radiofrequency Ablation (RFA) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AtriCure Endoscope + Radiofrequency Ablation (RFA) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Endoscope + Radiofrequency Ablation (RFA) Market Competition, by Players
3.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Endoscope + Radiofrequency Ablation (RFA) Players Market Share
3.2.2 Top 10 Endoscope + Radiofrequency Ablation (RFA) Players Market Share
3.3 Market Competition Trend
4 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Regions
4.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue and Market Share by Regions
4.2 North America Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
4.3 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
4.5 South America Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
5 North America Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries
5.1 North America Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries (2013-2018)
5.2 USA Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
5.3 Canada Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
5.4 Mexico Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
6 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries
6.1 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries (2013-2018)
6.2 Germany Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
6.3 UK Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
6.4 France Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
6.5 Russia Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
6.6 Italy Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries
7.1 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries (2013-2018)
7.2 China Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
7.3 Japan Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
7.4 Korea Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
7.5 India Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
8 South America Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries
8.1 South America Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries (2013-2018)
8.2 Brazil Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
8.3 Argentina Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
8.4 Colombia Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Endoscope + Radiofrequency Ablation (RFA) by Countries
9.1 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
9.3 UAE Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
9.4 Egypt Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
9.6 South Africa Endoscope + Radiofrequency Ablation (RFA) Revenue and Growth Rate (2013-2018)
10 Global Endoscope + Radiofrequency Ablation (RFA) Market Segment by Type
10.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue and Market Share by Type (2013-2018)
10.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Forecast by Type (2018-2023)
10.3 Focal Ablation Revenue Growth Rate (2013-2023)
10.4 Others Revenue Growth Rate (2013-2023)
11 Global Endoscope + Radiofrequency Ablation (RFA) Market Segment by Application
11.1 Global Endoscope + Radiofrequency Ablation (RFA) Revenue Market Share by Application (2013-2018)
11.2 Endoscope + Radiofrequency Ablation (RFA) Market Forecast by Application (2018-2023)
11.3 Cardiology Application Revenue Growth (2013-2018)
11.4 Pain Management Revenue Growth (2013-2018)
11.5 Oncology Application Revenue Growth (2013-2018)
11.6 Other Application Revenue Growth (2013-2018)
12 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Forecast (2018-2023)
12.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Forecast (2018-2023)
12.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Forecast by Regions (2018-2023)
12.3 North America Endoscope + Radiofrequency Ablation (RFA) Revenue Market Forecast (2018-2023)
12.4 Europe Endoscope + Radiofrequency Ablation (RFA) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Revenue Market Forecast (2018-2023)
12.6 South America Endoscope + Radiofrequency Ablation (RFA) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Endoscope + Radiofrequency Ablation (RFA) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Endoscope + Radiofrequency Ablation (RFA) Picture
Table Product Specifications of Endoscope + Radiofrequency Ablation (RFA)
Table Global Endoscope + Radiofrequency A
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
